PERSONALIZED THERAPY IN CARDIOLOGY: THE ROLE OF PHARMACOGENETICS AND BIOMARKERS IN THE SELECTION OF ANTIHYPERTENSIVE AND ANTIPLATELET AGENTS - POTENTIAL AND LIMITATIONS OF IMPLEMENTATION. Genetics and Mol. Res. Published online May 6, 2026. doi:10.4238/z3e7ft80